OTUD5 Rabbit mAb

Catalog No.: F1344

  • Lane 1: K562
    Lane 2: HCT116
    Lane 3: A549
    Lane 4: U2OS
サイズ (液体) 価格(税別) 在庫状況
JPY 19800 国内在庫なし(納期7~10日)
JPY 49500 国内在庫なし(納期7~10日)
JPY 74200 お問い合わせ

代表番号: 045-509-1970|電子メール:sales@selleck.co.jp
よく尋ねられる質問

キーポイント

タンパク質の局在:細胞核
WB
RIPA/Nuclear Lysis Buffer バッファーでのライセート調製を推奨します。

使用情報

Dilution
1:1000
1:50
Application
WB, IP
Source
Rabbit
Reactivity
Human, Rat, Monkey
Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage (from the date of receipt)
–20°C (avoid freeze-thaw cycles), 2 years
Predicted MW Observed MW
75 kDa 75 kDa
*なぜ予測分子量と実際の分子量が異なるのか?
下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
ポジティブコントロール 293T; K-562; HCT 116; A549; U-2 OS; Jurkat; Daudi; RBL-2H3; C6
ネガティブコントロール 293T (transfected with siRNA targeting human OTUD5)

サンプル処理データの例

サンプル 処理状況
293T Tansfection (siRNA targeting hμMan OTUD5)
COS-7 Low expression
クリックして、さらに多くのサンプルデータを表示

*異なるヒト由来細胞や組織における発現量の予測については、以下をご参照ください: http://www.proteinatlas.org

プロトコール

WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
 

Datasheet & SDS

生物学的記述

Specificity

OTUD5 Rabbit mAb recognizes endogenous levels of total OTUD5 protein.

Uniprot ID
Q96G74
Clone
F16F3
Background

OTUD5 (OTU Deubiquitinase 5) is a cysteine protease with deubiquitinase activity and a member of the ovarian tumor protease (OTU) family. The human OTUD5 protein consists of 571 amino acids with a molecular weight of approximately 60 kDa. It has two key structural domains: an OTU catalytic domain responsible for its deubiquitinase activity and a ubiquitin-interacting motif (UIM) domain, which is crucial for its function and interaction with proteins like STING, SPT16, TRIM25, TP53, and PDCD5. The N-terminal region (1-212 amino acids) of OTUD5 is essential for its interaction with UBR5 and YAP. OTUD5 is a key regulator of various physiological processes, including immune signaling, DNA damage repair, and cellular responses to stress. It negatively regulates type I interferon (IFN-I) expression by downregulating TRAF3 K63-linked polyubiquitination and promotes DNA repair by stabilizing Ku80 or regulating FACT-dependent transcription at damaged chromatin. In myocardial ischemia/reperfusion, OTUD5 is involved in preventing ferroptosis by protecting GPX4 from degradation. OTUD5 also exerts oncogenic effects by deubiquitinating proteins like TRIM25, TP53, PDCD5, and PTEN, influencing cancer progression through the mTOR and Hippo signaling pathways. Thus, OTUD5 is implicated in inflammation, cancer, genetic disorders, and cardiovascular diseases, making it a potential therapeutic target.

References

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

大学・企業名を記入してください
名前を記入してください
電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
お問い合わせ内容をご入力ください